Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Respiratory Tract Neoplasm”

935 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 935 results

Testing effectiveness (Phase 2)Study completedNCT02568449
What this trial is testing

Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent

Who this might be right for
Recurrent Pleural Malignant MesotheliomaStage IV Pleural Mesothelioma
Barbara Ann Karmanos Cancer Institute 20
Early research (Phase 1)Study completedNCT04330664
What this trial is testing

Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)

Who this might be right for
Advanced CancerMetastatic CancerMalignant Neoplastic Disease
Mirati Therapeutics Inc. 86
Early research (Phase 1)Not Yet RecruitingNCT07110363
What this trial is testing

A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer

Who this might be right for
Advanced Malignant Solid TumorAdvanced Lung CancerNon-Small Cell Lung Cancer+1 more
Biotroy Therapeutics 58
Not applicableNo Longer AvailableNCT03874455
What this trial is testing

Tazemetostat Expanded Access Program for Adults With Solid Tumors

Who this might be right for
Epithelioid Sarcoma (Ex-US Only)Spindle Cell SarcomaSinonasal Carcinoma+17 more
Epizyme, Inc.
Not applicableStudy completedNCT01773655
What this trial is testing

Clinical and Histopathologic Characteristics of BAP1 Mutations

Who this might be right for
Malignant Pleural Mesothelioma (MPM)Choroidal NevusPrimary Uveal Melanoma (UM)+3 more
Memorial Sloan Kettering Cancer Center 196
Not applicableUnknownNCT05872126
What this trial is testing

Video Assisted Thoracoscopic Surgery (VATS) - Surgical Pleurodesis vs Tube Drainage in Management of Malignant Pleural Effusion (MPE)

Who this might be right for
Malignant Pleural EffusionThoracic Cancer
Assiut University 60
Testing effectiveness (Phase 2)Study completedNCT04115111
What this trial is testing

Diadem to Investigate the Activity and Safety of Durvalumab

Who this might be right for
Pleura Mesothelioma
Mario Negri Institute for Pharmacological Research 57
Testing effectiveness (Phase 2)Study completedNCT00564733
What this trial is testing

FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer

Who this might be right for
Malignant Pleural EffusionStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
University of Washington 55
Large-scale testing (Phase 3)Ended earlyNCT00858364
What this trial is testing

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Who this might be right for
Non-Small Cell Lung CancerAnemiaCancer+1 more
Amgen 2,549
Early research (Phase 1)Active Not RecruitingNCT04162015
What this trial is testing

Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center 22
Not applicableStudy completedNCT03276715
What this trial is testing

Prognostic Factors on Malignant Pleural Effusion

Who this might be right for
Pleural Effusion, MalignantLung Cancer
The University of Hong Kong 233
Testing effectiveness (Phase 2)Study completedNCT01112293
What this trial is testing

Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma

Who this might be right for
Pleural Malignant Mesothelioma
Abramson Cancer Center at Penn Medicine 14
Testing effectiveness (Phase 2)Study completedNCT02049060
What this trial is testing

Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin

Who this might be right for
Malignant Pleural MesotheliomaNonsquamous Nonsmall Cell Neoplasm of Lung
Armando Santoro, MD 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT05585320
What this trial is testing

A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorPancreatic AdenocarcinomaMalignant Melanoma (Cutaneous)+1 more
Immuneering Corporation 209
Not applicableEnded earlyNCT02566421
What this trial is testing

Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery

Who this might be right for
Metastatic NeoplasmRecurrent NeoplasmRecurrent Non-Small Cell Lung Carcinoma+4 more
Wake Forest University Health Sciences 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT05451849
What this trial is testing

A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer

Who this might be right for
MesotheliomaMesotheliomas PleuralMesothelioma, Malignant+14 more
TCR2 Therapeutics 6
Early research (Phase 1)Looking for participantsNCT06726564
What this trial is testing

MT027 in Patients with Pleural Malignant Tumors

Who this might be right for
Advanced Malignant Solid TumorMalignant Pleural EffusionPleura Carcinoma+3 more
Suzhou Maximum Bio-tech Co., Ltd. 18
Early research (Phase 1)Looking for participantsNCT06375187
What this trial is testing

GC203 TIL in Advanced Malignant Solid Tumors

Who this might be right for
Solid TumorGynecologic CancerBreast Cancer+2 more
Shanghai Juncell Therapeutics 18
Testing effectiveness (Phase 2)Study completedNCT00700336
What this trial is testing

Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)

Who this might be right for
Malignant Pleural MesotheliomaSolid Tumors
CanBas Co. Ltd. 69
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Load More Results